Literature DB >> 11390955

Vascular endothelium: checkpoint for inflammation and immunity.

B C Biedermann1.   

Abstract

Vascular endothelial cells play a threefold role in the interaction with leukocytes. First, they are gatekeepers in leukocyte recruitment to inflammatory foci and lymphocyte homing to secondary lymphoid organs. Second, they modulate leukocyte activation. Finally, they are targets of leukocyte-derived molecules, resulting either in endothelial cell activation or death.

Entities:  

Mesh:

Year:  2001        PMID: 11390955     DOI: 10.1152/physiologyonline.2001.16.2.84

Source DB:  PubMed          Journal:  News Physiol Sci        ISSN: 0886-1714


  6 in total

Review 1.  Extraluminal factors contributing to inflammatory bowel disease.

Authors:  Arvind Batra; Thorsten Stroh; Britta Siegmund
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

Review 2.  Allogeneic reactivity-mediated endothelial cell complications after HSCT: a plea for consensual definitions.

Authors:  Simona Pagliuca; David Michonneau; Flore Sicre de Fontbrune; Aurélien Sutra Del Galy; Aliénor Xhaard; Marie Robin; Régis Peffault de Latour; Gérard Socie
Journal:  Blood Adv       Date:  2019-08-13

3.  The role of vascular endothelium and exosomes in human protozoan parasitic diseases.

Authors:  Sanjay Varikuti; Bijay Kumar Jha; Erin A Holcomb; Jodi C McDaniel; Manjula Karpurapu; Nidhi Srivastava; Bradford S McGwire; Abhay R Satoskar; Narasimham L Parinandi
Journal:  Vessel Plus       Date:  2020-09-27

4.  Luteolin suppresses inflammation through inhibiting cAMP-phosphodiesterases activity and expression of adhesion molecules in microvascular endothelial cells.

Authors:  Xueli Kong; Guitao Huo; Shurong Liu; Fengnan Li; Wu Chen; Daixun Jiang
Journal:  Inflammopharmacology       Date:  2018-10-01       Impact factor: 4.473

5.  Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel disease.

Authors:  Franco Scaldaferri; Miquel Sans; Stefania Vetrano; Cristina Graziani; Raimondo De Cristofaro; Bruce Gerlitz; Alessandro Repici; Vincenzo Arena; Alberto Malesci; Julian Panes; Brian W Grinnell; Silvio Danese
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

6.  Cordycepin inhibits lipopolysaccharide (LPS)-induced tumor necrosis factor (TNF)-α production via activating amp-activated protein kinase (AMPK) signaling.

Authors:  Jian-Li Zhang; Ying Xu; Jie Shen
Journal:  Int J Mol Sci       Date:  2014-07-08       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.